h
Let’s Work Together
[email protected]

Meet Arrosa, the perfect theme to elevate your online presentation with.

Search here!
Ander Pino

Ander Pino

Docteur en Biotechnologie

Chercheur dans le Laboratoire R&D de médecine régénérative.

Diplôme en biotechnologie (Université de León)

Doctorat en biotechnologie (UPV-EHU)

CUM LAUDE et Mention au Prix Extraordinaire : Thérapies autologues en dermatologie régénérative

Master : Recherche sociale en communication scientifique. (Université Internationale de Valence)

Baccalauréat en biotechnologie (Université du Vermont)

Chercheur au Laboratoire R&D de Médecine Régénérative

Responsable de la formation en médecine régénérative

Chargé de cours du Master en Thérapie Régénérative Orale et Faciale et Réhabilitation en Implantologie Orale

Articles publiés

Accidental events or surgical procedures usually lead to tissue injury. Fibrin sealants have proven to optimize the healing process but have some drawbacks due to their allogeneic nature. Autologous fibrin sealants present several advantages. The aim of this study is to evaluate the performance of a new autologous fibrin sealant based on Endoret®PRGF® technology (E-sealant). One of the most widely used commercial fibrin sealants (Tisseel®) was included as comparative Control.

Skin injury and wound healing is an inevitable event during lifetime. However, several complications may hamper the regeneration of the cutaneous tissue and lead to a chronic profile that prolongs patient recovery. Platelet-rich plasma is rising as an effective and safe alternative to the management of wounds

Over the last three decades, there has been special interest in developing drugs that mimic the characteristics of natural tears for use it in the treatment of several ocular surface disorders. Interestingly, the composition of blood plasma is very similar to tears. Therefore, different blood-derived products like autologous serum (AS) and plasma rich in growth factors (PRGF) have been developed for the treatment of diverse ocular pathologies.

Cutaneous autoimmune and inflammatory diseases are a major burden of global disease and many lack effective treatments that can derive in different dermatoses like atopic dermatitis. Despite the increase prevalence and the high health-care costs worldwide, the heterogeniety and multifactoriality of these diseases mean that effective treatment options are scarce.